FDA Adverse Event Injury Summary report: N

ACRYSOF IQ RESTOR SINGLEPIECE IOL

MDR report key: 4791655 · Received May 22, 2015

Report

Report Number
1119421-2015-05426
Event Type
Injury
Date Received
May 22, 2015
Report Date
August 11, 2015
Manufacturer
ALCON RESEARCH, LTD. - HUNTINGTON
Product Code
MFK
PMA / PMN Number
P040020
Removal / Correction Number
NA
Adverse Event
Yes
Product Problem
Yes
Report Source
Manufacturer report
Reporter Location
NL
Reporter Occupation
OTHER HEALTH CARE PROFESSIONAL

Narratives

Additional Manufacturer Narrative · 1

EVALUATION SUMMARY: COMPLAINT HISTORY AND PRODUCT HISTORY RECORD COULD NOT BE REVIEWED BECAUSE THE JOURNAL ARTICLE DID NOT PROVIDE A VALID LOT NUMBER OR ANY IDENTIFICATION TRACEABLE TO THE MANUFACTURING DOCUMENTATION. ROOT CAUSE HAS NOT BEEN IDENTIFIED. ADDITIONAL INFORMATION IS NOT EXPECTED. VAN DER MOOREN, M. (2015). EXPLANTED MULTIFOCAL INTRAOCULAR LENSES. JOURNAL OF CATARACT AND REFRACTIVE SURGERY, 41, 873-877. (B)(4).

Additional Manufacturer Narrative · 1

CORRECTED INFORMATION PROVIDED. ARTICLE ATTACHED. THE MANUFACTURER INTERNAL REFERENCE NUMBER IS: (B)(4).

Additional Manufacturer Narrative · 1

THE MANUFACTURER INTERNAL REFERENCE NUMBER IS: (B)(4).

Description of Event or Problem · 1

A JOURNAL ARTICLE REPORTED A CASE IN WHICH A SINGLE-PIECE ACRYLIC INTRAOCULAR LENS (IOL) WAS EXPLANTED BECAUSE OF COMPLICATIONS RELATED TO THE PRESENCE OF DENSE GLISTENINGS IN THE BULK OF THE IOL OPTIC. THE PATIENT COMPLAINED ABOUT BLURRY OR HAZY VISION, DIFFICULTY READING AND DRIVING, GLARE AND HALOS. THE PATIENT WAS DIAGNOSED WITH AGE RELATED MACULAR DEGENERATION AS WELL AS PERIPHERAL POSTERIOR CAPSULE OPACIFICATION. SYMPTOMS RESOLVED FOLLOWING A LENS EXCHANGE. ADDITIONAL INFORMATION IS NOT EXPECTED.

Description of Event or Problem · 1

CORRECTION: THE PATIENT DID NOT EXPERIENCE HALOS AS WAS PREVIOUSLY REPORTED.

Devices

Seq Brand Generic Product Code Manufacturer Model Lot UDI-DI
336375 ACRYSOF IQ RESTOR SINGLEPIECE IOL LENS, MULTIFOCAL INTRAOCULAR MFK ALCON RESEARCH, LTD. - HUNTINGTON SN6AD3 ASKU

Patients

Seq Age Sex Outcome Treatment
1 77 YR Other| R